dr. birrer discusses recurrent ovarian cancer treatment
Published 12 years ago • 876 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
4:07
expert approaches for treating recurrent ovarian cancer
-
3:16
dr. michael birrer on bevacizumab in ovarian cancers
-
1:04
michael birrer discusses personalization of ovarian cancer care
-
1:58
dr. birrer on the approval process in ovarian cancer
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
2:34
dr. birrer on other targets in ovarian cancer
-
6:35
asco 2018: dr. birrer on practice-changing ovarian cancer studies
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
1:56
dr. birrer discusses the gog0218 and icon7 trials
-
1:50
dr. birrer on the ovarian cancer avastin os benefit
-
1:05
dr. memarzadeh on recurrence rates in ovarian cancer
-
1:49
dr. birrer on parp inhibitors in ovarian cancer
-
7:32
bevacizumab for recurrent ovarian cancer
-
2:30
dr. birrer on parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
6:44
sequencing for treatment for recurrent ovarian cancer
-
1:56
dr. birrer on parp inhibitors in ovarian cancer